-
State Regulators Bet on a Legal Difference Between Prediction Markets, Sports Gambling

Photo via Billy Tompkins/ZUMAPRESS/Newscom -
Invesco Doesn’t QQQuite Have the Votes for ETF’s Transition

Photo by Getty Images via Unsplash -
Silver ETFs on Track for Gold Medal in Performance This Year

Photo by Scottsdale Mint via Unsplash -
How Goldman’s $2B Innovator Deal Could Reshape ETF Consolidation

Photo by JESHOOTS.COM via Unsplash -
How Advisors Are Weighing the Risks of an AI Bubble

-
Spooked by Bitcoin? Here Are the 6 Biggest Ethereum and Solana ETFs

Image Credit: iStock, Chinnapong -
Dollar Stores Increasingly Make Sense for Crunched Consumers

Photo via Michael Siluk/UCG/Universal Images Group/Newscom -
Netflix Is Buying Warner Bros. So Who Changes Whom?

Photo via Thomas Imo/picture alliance / photothek.de/Newscom -
Even As Bitcoin Dips, Crypto ETFs Break Down TradFi Barriers

Photo illustration by Connor Lin / The Daily Upside -
Believe: Macy’s Posts Best Growth In Three Years as ‘Reimagine’ Strategy Pays Off

Photo by littleny via iStock -
Low-Key $3T Investment Firm Is Ready for Its Closeup

Photo via Vernon Yuen/Nexpher Images/Sipa USA -
White House Hits the Brakes on Fuel Economy Standards

Photo via Sipa USA/Newscom -
SEC Halts Filings of Highly Leveraged ETFs

Photo by ablokhin via iStock -
Tree Hugging or Greenwashing? BlackRock’s in ESG Hot Seat Either Way

Photo via Yuri Gripas -
Clients Want the Everything-Store Experience

Photo by Heidi Fin via Unsplash -
Vanguard Raises White Flag Over Crypto ETFs

Photo by Katherine McCormack via Unsplash -
Model Portfolios Decide Which ETFs Succeed. That Might Not Be a Good Thing

Photo by Vladislav Babienko via Unsplash -
How ETF Issuers Can Use AI to Target New Strategies

Photo by Getty Images via Unsplash
Advisor Upside
Financial advisor news, market insights, and practice management essentials.
-
Coca-Cola Tabs its Next CEO

Photo via Coca Cola -
Disney Licenses Play Dates for Mickey Mouse, ChatGPT in $1B OpenAI Deal

Photo via Disney/OpenAI -
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom
Delivering exclusive news and sharp analysis on finance and investing—all for free.





















